STOCKHOLM, April 28, 2022 /PRNewswire/ — Alzinova AB (publ) (FN STO: ALZ), a Swedish biopharma company developing treatments for Alzheimer’s disease by specifically targe… Read More

The Swedish biopharma company Alzinova AB developed a vaccine that can treat patients diagnosed with Alzheimer’s disease. The vaccine has been studied on animals, and it will now enter… Read More

geralt / Pixabay Background: Alzinova AB (Gothenburg) is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer’s disea… Read More